[go: up one dir, main page]

K. Dutta-Roy, Margaret J. Gordon, Collete Kelly, Kirsty Hunter, Lynn Crosbie, Tamsin Knight-Carpentar, Brent C. Williams, 1999 - Google Patents

Inhibitory effect of Ginkgo biloba extract on human platelet aggregation

K. Dutta-Roy, Margaret J. Gordon, Collete Kelly, Kirsty Hunter, Lynn Crosbie, Tamsin Knight-Carpentar, Brent C. Williams, 1999

View PDF
Document ID
11738302813136945131
Author
K. Dutta-Roy, Margaret J. Gordon, Collete Kelly, Kirsty Hunter, Lynn Crosbie, Tamsin Knight-Carpentar, Brent C. Williams A
Publication year
Publication venue
Platelets

External Links

Snippet

The effect of pure flavonoids and Gingko biloba extract (GBE) on human platelet aggregation was investigated. Most of the flavonoids and vitamin E did not affect platelet aggregation in platelet-rich plasma (PRP); however some of these flavonoids inhibited …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
K. Dutta-Roy, Margaret J. Gordon, Collete Kelly, Kirsty Hunter, Lynn Crosbie, Tamsin Knight-Carpentar, Brent C. Williams Inhibitory effect of Ginkgo biloba extract on human platelet aggregation
Gargiulo et al. The role of oxysterols in vascular ageing
Pignatelli et al. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide
Flammer et al. Human endothelial dysfunction: EDRFs
Céspedes et al. Antioxidant and cardioprotective activities of phenolic extracts from fruits of Chilean blackberry Aristotelia chilensis (Elaeocarpaceae), Maqui
K. Dutta-Roy, Lynn Crosbie, Margaret J. Gordon Effects of tomato extract on human platelet aggregation in vitro
Virgili et al. Procyanidins extracted from Pinus maritima (Pycnogenol®): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages
TW542721B (en) Dietary supplements containing natural ingredients
Kökçam et al. Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet’s disease
Lee et al. Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease
Teng et al. Antiplatelet actions of some coumarin compounds isolated from plant sources
EP1328268B1 (en) Combination of catechin and quercetin for pharmaceutical or dietary use
Jacobi et al. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures
Olas et al. Inhibition of oxidative stress in blood platelets by different phenolics from Yucca schidigera Roezl. bark
AU2002220617A1 (en) Combination of catechin and quercetin for pharmaceutical or dietary use
Mower et al. Inhibition in vitro of platelet aggregation and arachidonic acid metabolism by flavone
Lis et al. The anti-oxidative and hemostasis-related multifunctionality of L-chicoric acid, the main component of dandelion: An in vitro study of its cellular safety, antioxidant and anti-platelet properties, and effect on coagulation
Srivastava Vitamin E exerts antiaggregatory effects without inhibiting the enzymes of the arachidonic acid cascade in platelets
Yelisyeyeva et al. The effect of Amaranth oil on monolayers of artificial lipids and hepatocyte plasma membranes with adrenalin-induced stress
Garrido et al. Scavenger effect of a mango (Mangifera indica L.) food supplement’s active ingredient on free radicals produced by human polymorphonuclear cells and hypoxanthine–xanthine oxidase chemiluminescence systems
Massaro et al. Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factor-κB through antioxidant effects
Brown et al. Pharmacological Activity of Feverfew (Tanacetum parthenium (L.) Schultz‐Bip.): Assessment by Inhibition of Human Polymorphonuclear Leukocyte Chemiluminescence In‐vitro
Selley et al. Effect of 4-hydroxy-2, 3-trans-nonenal on platelet function
Lis et al. Anti-platelet activity of phytocompounds in various dandelion organs in human whole blood model in vitro
Ohlstein et al. Endothelin and platelet function